Manji, Gulam Abbas
- Columbia University · Internal Medicine (NIH department code)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #28,729
- R01 Holder
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2017 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2023 award categories
- Internal Medicine
NIH Funding · FY2023
Linked Award Amount
$405.8K
Full award amounts, FY2023
Award Records
1
Records listing this PI
Award-Linked Rank
#28,729
By linked amount among FY2023 PIs
Earliest Year Loaded
2017
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Manji, Gulam Abbas as a PI. Multi-PI records show the full award amount for context.
- 5R01FD005745-04R01Contact PIPhase 2 study of combination therapy with PLX3397 and sirolimus to target tumor-associated macrophages in malignant peripheral nerve sheath tumorsColumbia University · Internal Medicine (NIH department code)$405.8Kaward amount
Award organization
Organizations that administered FY2023 awards listing Manji, Gulam Abbas as a PI.
FY2023 award administered by Columbia University (NY).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2017First NIH AwardColumbia University
- 2017$500K Cumulative Funding
- 2020$1M Cumulative Funding
- 2020R01 Grant Holder